Senior Scientific Announces Issuance of U.S. Patent for the Detection, Measurement & Imaging of Cancer Cells Using Nanopartic...
23 May 2013 - 11:47PM
Business Wire
Senior Scientific, LLC, a unit of Manhattan Scientifics (OTCQB:
MHTX) and a developer of molecular imaging and nanobiotechnology
for the early detection and localization of cancer and other human
diseases, today announced that the United States Patent Office
(USPTO) has issued U.S. Patent No. 8,447,379 entitled “Detection,
measurement, and imaging of cells such as cancer and other biologic
substances using targeted nanoparticles and magnetic properties
thereof.”
The patent includes claims directed to detecting and measuring
biological substances such as cancer cells. The methods can be used
in humans, with no harmful radiation, and can find cancers much
earlier than is possible with conventional technologies.
The technology is based on the work of Edward R. Flynn, PhD, in
NanoMagnetic RelaxometryTM. The issued patent is further
confirmation of the pioneering nature of Dr. Flynn’s work.
Gerald Grafe, president of Senior Scientific, said, “We are
moving forward and making progress to bring Dr. Flynn’s technology
to market, and this patent is an important addition to our
intellectual property estate protecting the commercial value of the
work.”
Dr. Flynn, Chief Scientist of Senior Scientific, said, “I am
encouraged to see my work heading to market, and pleased that we
now also have this patent to protect the business.”
Senior Scientific LLC, a unit of the company
About Manhattan Scientifics
Manhattan Scientifics Inc. (http://www.mhtx.com), located in New
Mexico, New York and Montreal, is focused on technology transfer
and commercialization of disruptive technologies in the
nano-medicine space. It has achieved several critical milestones in
the development of its proprietary technology for the early
detection and treatment of cancer. The company also is diligently
working with its commercial partners to build super-strength metals
and alloys to make extremely light weight products. The company is
developing commercial medical prosthetics applications for its
ultra-fine grain metals and plans to commercialize the cancer
research work and nano-medical applications developed by Senior
Scientific LLC, a unit of the company.
About Senior Scientific
Senior Scientific, LLC (http://www.seniorscientific.com) is a
New Mexico Company with research facilities located at the
University of New Mexico Science and Technology Park in
Albuquerque, New Mexico and longstanding relationships with the
University of New Mexico Health Sciences Center, and the Center for
Integrated Nanotechnology (CINT) at Sandia National Laboratory. The
Company’s focus is in the emerging field of molecular imaging and
nanobiotechnology for the early detection and localization of
cancer and other human diseases, and is the leader in a technology
called Nanomagnetic Relaxometry (“NMR”). Its proprietary
technologies and methods employ magnetic nanoparticles targeted
towards cells associated with cancer and other diseases, and detect
those cells tagged with magnetic nanoparticles through
sophisticated magnetic sensors.
Forward-looking statement
This press release contains forward-looking statements, which
are subject to a number of risks, assumptions and uncertainties
that could cause the Company's actual results to differ materially
from those projected in such forward-looking statements. Management
at Manhattan Scientifics believes that purchase of its shares
should be considered to be at the high end of the risk spectrum.
Forward-looking statements speak only as of the date made and are
not guarantees of future performance. We undertake no obligation to
publicly update or revise any forward-looking statements.
Manhattan Scientifics (PK) (USOTC:MHTX)
Historical Stock Chart
From Apr 2024 to May 2024
Manhattan Scientifics (PK) (USOTC:MHTX)
Historical Stock Chart
From May 2023 to May 2024